Bristol Myers Squibb Reports on Shareholder Votes

Ticker: CELG-RI · Form: 8-K · Filed: May 7, 2025 · CIK: 14272

Bristol Myers Squibb Co 8-K Filing Summary
FieldDetail
CompanyBristol Myers Squibb Co (CELG-RI)
Form Type8-K
Filed DateMay 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, debt-issuance, shareholder-vote

Related Tickers: BMY

TL;DR

BMY filed an 8-K on May 6th about shareholder votes and notes.

AI Summary

Bristol Myers Squibb Company filed an 8-K on May 7, 2025, reporting on matters submitted to a vote of security holders on May 6, 2025. The filing details various financial instruments including "One750NotesDue2035Member" and "One000NotesDue2025Member", as well as "CelgeneContingentValueRightsMember" and common stock.

Why It Matters

This filing indicates key corporate actions and financial instrument statuses that could impact investor decisions and the company's financial structure.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate actions and does not appear to contain significant new risks.

Key Players & Entities

  • BRISTOL MYERS SQUIBB CO (company) — Filer
  • May 6, 2025 (date) — Date of earliest event reported
  • May 7, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 22-0790350 (identifier) — IRS Employer Identification Number
  • Route 206 & Province Line Road , Princeton , New Jersey 08543 (address) — Address of Principal Executive Office
  • CelgeneContingentValueRightsMember (financial_instrument) — Financial instrument mentioned
  • One750NotesDue2035Member (financial_instrument) — Financial instrument mentioned
  • One000NotesDue2025Member (financial_instrument) — Financial instrument mentioned

FAQ

What was the primary purpose of this 8-K filing?

The primary purpose was to report on matters submitted to a vote of security holders on May 6, 2025.

On what date was this 8-K filing submitted?

The filing was submitted on May 7, 2025.

What is Bristol Myers Squibb Company's state of incorporation?

Bristol Myers Squibb Company is incorporated in Delaware.

What are some of the financial instruments mentioned in the filing?

The filing mentions 'One750NotesDue2035Member', 'One000NotesDue2025Member', and 'CelgeneContingentValueRightsMember'.

What is the address of Bristol Myers Squibb's principal executive office?

The address is Route 206 & Province Line Road, Princeton, New Jersey 08543.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding BRISTOL MYERS SQUIBB CO (CELG-RI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.